Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy Volunteers
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to compare the pharmacodynamics (course of the blood
glucose-lowering effect and duration of effect) and pharmacokinetics (course of the
concentration of study medication in the blood) of a single subcutaneous dose of 0.2 units/kg
of insulin glulisine and insulin aspart in a direct head-to-head comparison during two
euglycemic glucose clamps in healthy subjects.